Amphotericin b
Abelcet, Ambisome, Amphotec, Fungizone (amphotericin b) is a small molecule pharmaceutical. Amphotericin b was first approved as Abelcet on 1982-01-01. It is used to treat aids-related opportunistic infections, aspergillosis, blastomycosis, chronic mucocutaneous candidiasis, and coccidioidomycosis amongst others in the USA.
Trade Name | Abelcet, Ambisome, Amphotec, Fungizone |
---|---|
Common Name | Amphotericin b |
Indication | aids-related opportunistic infections, aspergillosis, blastomycosis, chronic mucocutaneous candidiasis, coccidioidomycosis, cryptococcal meningitis, cutaneous candidiasis, cystitis, fungemia, histoplasmosis, mycoses, neutropenia, paracoccidioidomycosis, peritonitis, sporotrichosis, urinary tract infections, visceral leishmaniasis, zygomycosis |
Drug Class |